Cargando…
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the n...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922506/ https://www.ncbi.nlm.nih.gov/pubmed/29719740 http://dx.doi.org/10.7759/cureus.2238 |
_version_ | 1783318207894913024 |
---|---|
author | Tsui, James M Mihalcioiu, Catalin Cury, Fabio L |
author_facet | Tsui, James M Mihalcioiu, Catalin Cury, Fabio L |
author_sort | Tsui, James M |
collection | PubMed |
description | In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the neck and with numerous pulmonary metastases. Immunotherapy with pembrolizumab was started, with initial good response and reduction in the size of the lesion in the neck. The regression, however, was short-lived, as the mass quickly grew at a remarkable rate and the lung lesions progressed significantly. Palliative local radiation of 24 Gy in three fractions delivered at days zero, seven, and 21 to the neck mass was eventually given with the goal to alleviate symptoms. An immediate tumor regression was observed after the first fraction of radiotherapy. Remarkably, the lung lesions had also started regressing following radiation. We believe this to be a case of abscopal effect witnessed during the delivery of radiotherapy. A review of the recent literature is also presented here. |
format | Online Article Text |
id | pubmed-5922506 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-59225062018-05-01 Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab Tsui, James M Mihalcioiu, Catalin Cury, Fabio L Cureus Radiation Oncology In this case report, we present the clinical course of a woman with locally advanced mucosal melanoma of the oral cavity. She was initially treated with surgery with adjuvant local radiation of 50 Gy in 20 fractions. She quickly relapsed with an aggressive regional recurrence of the disease on the neck and with numerous pulmonary metastases. Immunotherapy with pembrolizumab was started, with initial good response and reduction in the size of the lesion in the neck. The regression, however, was short-lived, as the mass quickly grew at a remarkable rate and the lung lesions progressed significantly. Palliative local radiation of 24 Gy in three fractions delivered at days zero, seven, and 21 to the neck mass was eventually given with the goal to alleviate symptoms. An immediate tumor regression was observed after the first fraction of radiotherapy. Remarkably, the lung lesions had also started regressing following radiation. We believe this to be a case of abscopal effect witnessed during the delivery of radiotherapy. A review of the recent literature is also presented here. Cureus 2018-02-27 /pmc/articles/PMC5922506/ /pubmed/29719740 http://dx.doi.org/10.7759/cureus.2238 Text en Copyright © 2018, Tsui et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiation Oncology Tsui, James M Mihalcioiu, Catalin Cury, Fabio L Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title | Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title_full | Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title_fullStr | Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title_full_unstemmed | Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title_short | Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab |
title_sort | abscopal effect in a stage iv melanoma patient who progressed on pembrolizumab |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922506/ https://www.ncbi.nlm.nih.gov/pubmed/29719740 http://dx.doi.org/10.7759/cureus.2238 |
work_keys_str_mv | AT tsuijamesm abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab AT mihalcioiucatalin abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab AT curyfabiol abscopaleffectinastageivmelanomapatientwhoprogressedonpembrolizumab |